biotech news today glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating What's next for GLP-1 innovation:
Description
SGLT-2 inhibitors reduce mortality in lower-risk patients, although absolute benefits are smaller
Anesthesiologists depend on fasting guidelines to reduce that risk, but GLP-1induced gastroparesis can render standard fasting times inadequate
2023;9(4): eade1444
Liraglutide (Saxenda) for weight management escalates weekly from 0.6 mg to a maintenance dose of 3 mg daily
Aim to consume 2030 grams of protein within one to two hours after strength training
